The American Diabetes Association (ADA)“Standards of Care in Diabetes” includes the
ADA's current clinical practice recommendations and is intended to provide the components …

The American Diabetes Association (ADA)“Standards of Care in Diabetes” includes the
ADA's current clinical practice recommendations and is intended to provide the components …

The significant and growing global prevalence of diabetes continues to challenge people
with diabetes (PwD), healthcare providers, and payers. While maintaining near-normal …

Objective The objective of this clinical practice guideline is to provide updated and new
evidence-based recommendations for the comprehensive care of persons with diabetes …

Background The possible advantage of hybrid closed-loop therapy (ie, artificial pancreas)
over sensor-augmented pump therapy in very young children with type 1 diabetes is …

Objective To provide evidence-based recommendations regarding the use of advanced
technology in the management of persons with diabetes mellitus to clinicians, diabetes-care …

OBJECTIVE Advances in diabetes technology have transformed the treatment paradigm for
type 1 diabetes, yet the burden of disease is significant. We report on a pivotal safety study …

Advances in diabetes technologies have enabled the development of automated closed-
loop insulin delivery systems. Several hybrid closed-loop systems have been …

Despite over 100 years of insulin therapy, glycemia remains suboptimal for many individuals
living with diabetes. Data from international diabetes registries highlight that most youth with …

Background: The t: slim X2™ insulin pump with Control-IQ® technology from Tandem
Diabetes Care is an advanced hybrid closed-loop system that was first commercialized in …